Medical Procedures
Explore procedure pages with patient-friendly context about preparation, expectations, and recovery.
All medical procedures (122,362)
Other
ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid
Other
ePHEDrine+Pseudoephedrine [Measurement] in Urine
Other
ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid
Other
ePHEDrine+Pseudoephedrine [Presence] in Specimen
Other
ePHEDrine+Pseudoephedrine [Presence] in Urine
Other
fentaNYL [Mass/volume] in Body fluid
Other
fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Other
fentaNYL [Mass/volume] in Unknown substance
Other
fentaNYL [Mass/volume] in Urine
Other
fentaNYL [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
Other
fentaNYL [Mass/volume] in Urine by Confirmatory method
Other
fentaNYL [Mass] of Dose
Other
fentaNYL [Measurement] in Urine
Other
fentaNYL [Presence] in Cord tissue by Confirmatory method
Other
fentaNYL [Presence] in Cord tissue by Screen method
Other
fentaNYL [Presence] in Gastric fluid
Other
fentaNYL [Presence] in Saliva (oral fluid) by Screen method
Other
fentaNYL [Presence] in Specimen
Other
fentaNYL [Presence] in Urine
Other
fentaNYL [Presence] in Urine by Confirmatory method
Other
fentaNYL [Presence] in Urine by Screen method
Other
fentaNYL [Z-score] in Urine
Other
fentaNYL and Norfentanyl panel - Gastric fluid
Other
fentaNYL and Norfentanyl panel - Specimen
Other
fentaNYL and Norfentanyl panel - Urine
Other
fentaNYL cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Other
fentaNYL cutoff [Mass/volume] in Urine for Confirmatory method
Other
fentaNYL cutoff [Mass/volume] in Urine for Screen method
Other
fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method
Other
fentaNYL+Norfentanyl [Presence] in Urine by Screen method
Other
fentaNYL/Creatinine [Mass Ratio] in Urine
Other
fluPHENAZine [Mass/volume] in Urine
Other
fluPHENAZine [Mass] of Dose
Other
fluPHENAZine [Measurement] in Urine
Other
fluPHENAZine [Moles/volume] in Gastric fluid
Other
fluPHENAZine [Moles/volume] in Specimen
Other
fluPHENAZine [Moles/volume] in Urine
Other
fluPHENAZine [Presence] in Urine
Other
fluvoxaMINE [Mass/volume] in Urine by Confirmatory method
Other
fluvoxaMINE [Measurement] in Urine
Other
fluvoxaMINE [Moles/volume] in Gastric fluid
Other
fluvoxaMINE [Moles/volume] in Specimen
Other
fluvoxaMINE [Moles/volume] in Urine
Other
fluvoxaMINE [Presence] in Specimen
Other
fluvoxaMINE [Presence] in Urine
Diagnostic
g10 specific IgE antibody measurement
g10 specific IgE antibody measurement — clinical procedure (SNOMED CT 392295002).
Diagnostic
gamma-Aminobutyrate measurement
gamma-Aminobutyrate measurement — clinical procedure (SNOMED CT 104679007).
Diagnostic
gamma-Benzene hexachloride measurement
gamma-Benzene hexachloride measurement — clinical procedure (SNOMED CT 121279006).
Diagnostic
gamma-Glutamylcysteine synthetase measurement
gamma-Glutamylcysteine synthetase measurement — clinical procedure (SNOMED CT 104680005).
Diagnostic
gamma-Glutamyltransferase/aspartate amino transferase ratio measurement
gamma-Glutamyltransferase/aspartate amino transferase ratio measurement — clinical procedure (SNOMED CT 104681009).
Other
glipiZIDE [Mass/volume] in Specimen
Other
glipiZIDE [Mass/volume] in Urine
Other
glipiZIDE [Presence] in Specimen
Other
glipiZIDE [Presence] in Urine
Other
glyBURIDE [Mass/volume] in Specimen
Other
glyBURIDE [Mass/volume] in Urine
Other
glyBURIDE [Presence] in Specimen
Other
guaiFENesin/Creatinine [Mass Ratio] in Urine by Confirmatory method
Other
heparan-alpha-glucosaminide N-acetyltransferase [Enzymatic activity/volume] in DBS
Other
howRu
Other
howRu score [R-Outcomes]
Other
howRwe panel [R-Outcomes]
Other
howRwe score [R-Outcomes]
Other
hydrALAZINE [Mass/volume] in Urine
Other
hydrALAZINE [Presence] in Urine
Other
hydrOXYzine [Mass/volume] in Urine
Other
hydrOXYzine [Mass] of Dose
Other
hydrOXYzine [Measurement] in Urine
Other
hydrOXYzine [Moles/volume] in Gastric fluid
Other
hydrOXYzine [Moles/volume] in Specimen
Other
hydrOXYzine [Moles/volume] in Urine
Other
hydrOXYzine [Presence] in Urine
Other
hydroCHLOROthiazide [Mass/time] in 24 hour Urine
Other
hydroCHLOROthiazide [Mass/volume] in Urine
Other
hydroCHLOROthiazide [Mass] of Dose
Other
hydroCHLOROthiazide [Measurement] in Urine
Other
hydroCHLOROthiazide [Presence] in 24 hour Urine
Other
hydroCHLOROthiazide [Presence] in Urine
Other
i-1 blood group antibody identification
i-1 blood group antibody identification — clinical procedure (SNOMED CT 104054008).
Other
i-1 blood group phenotype determination
i-1 blood group phenotype determination — clinical procedure (SNOMED CT 103949005).
Other
i-2 blood group antibody identification
i-2 blood group antibody identification — clinical procedure (SNOMED CT 104055009).
Other
i-2 blood group phenotype determination
i-2 blood group phenotype determination — clinical procedure (SNOMED CT 103950005).
Other
interRAI Acute Care (AC) Hospital Document
Other
interRAI Community Health Assessment (CHA) Document
Other
interRAI Community Health Assessment - Assisted Living Supplement (CHA-AL) Document
Other
interRAI Community Health Assessment - Deafblind Supplement (CHA-Db) Document
Other
interRAI Community Health Assessment - Functional Supplement (CHA-FS) Document
Other
interRAI Community Health Assessment - Mental Health Supplement (CHA-MH) Document
Other
interRAI Contact Assessment (CA) Document
Other
interRAI Emergency Screener for Psychiatry (ESP) Document
Other
interRAI Home Care (HC) Document
Other
interRAI Long Term Care Facility (LTCF) Document
Other
interRAI Palliative Care (PC) Document
Other
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Tissue by Molecular genetics method
Other
lamiVUDine [Susceptibility]
Other
lamiVUDine [Susceptibility] by Genotype method
Other
lamiVUDine [Susceptibility] by Phenotype method
Other
lamiVUDine or Emtricitabine [Susceptibility] by Genotype method